5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

If I’d invested £1k in Amazon stock when it went public, here’s what I’d have today

Amazon stock has been one of the biggest winners over the last couple of decades. Muhammad Cheema takes a look…

Read more »

Investing Articles

If I’d put £5,000 in Nvidia stock 5 years ago, here’s what I’d have now

Nvidia stock has been a great success story in the past few years. This Fool breaks down how much he'd…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Could investing in a Shein IPO make my ISA shine?

With chatter that London might yet see a Shein IPO, our writer shares his view on some possible pros and…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The FTSE 100 reached record highs in April! Here’s what investors should consider buying in May

The FTSE 100 continues to impress in 2024 as last month it reached new highs. Here are two stocks investors…

Read more »

Investing Articles

Despite hitting a 52-week high, Coca-Cola HBC stock still looks great value

Our writer reckons one flying UK share that has been participating in the recent FTSE 100 bull run remains a…

Read more »

Investing Articles

Is this the best stock to invest in right now?

Roland Head explains why he likes this FTSE 250 business so much and wonders if it could be the best…

Read more »

Cheerful young businesspeople with laptop working in office
Investing Articles

With impressive 7% dividend yields, I’d seriously consider these 2 popular British shares to buy in May

Picking the right dividend shares to buy can result in spectacular returns. This Fool is weighing the prospects of these…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

It might not be an aristocrat but Legal & General is still a class dividend stock!

For each of the past 14 years, this FTSE 100 dividend stock has either maintained or increased its payout. Our…

Read more »